11-氧代C19类固醇是多囊卵巢综合征中的主要雄激素
该研究纳入114例多囊卵巢综合征(PCOS)患者和49例健康对照,采用液相色谱-串联质谱测定血清雄激素,气相色谱-质谱分析24小时尿雄激素排泄。结果显示PCOS患者血清11-氧代雄激素及尿11β-羟基雄烷酮显著升高,11-氧代雄激素占总血清雄激素比例在PCOS组为53.0%(四分位距48.7至60.3)vs 对照组44.0%(四分位距32.9至54.9),P<0.0001,且与胰岛素抵抗标志物显著相关。
要点
- PCOS患者血清11-氧代雄激素及尿11β-羟基雄烷酮显著高于对照。
- 11-氧代雄激素占总血清雄激素比例PCOS组53.0% vs 对照组44.0%,P<0.0001。
- 血清11β-羟基雄烯二酮和11-酮雄烯二酮与胰岛素抵抗标志物显著相关。
核心结论
- 11-氧代雄激素代表PCOS女性循环雄激素的大部分,并与代谢风险标志物密切相关。
研究设计与样本
- 研究纳入114例PCOS女性和49例健康对照,采用液相色谱-串联质谱测定血清雄激素,气相色谱-质谱分析24小时尿雄激素排泄,并测定空腹血浆胰岛素和葡萄糖以评估胰岛素抵抗。
主要发现
- PCOS患者血清睾酮(P<0.001)、雄烯二酮(P<0.001)和脱氢表雄酮(P<0.01)显著升高。
- PCOS患者血清11β-羟基雄烯二酮、11-酮雄烯二酮、11β-羟基睾酮和11-酮睾酮以及尿11β-羟基雄烷酮显著高于对照。
- 11-氧代雄激素占总血清雄激素比例PCOS组为53.0%(四分位距48.7至60.3)vs 对照组44.0%(四分位距32.9至54.9),P<0.0001。
- 肥胖(n=51)和非肥胖(n=63)PCOS患者的11-氧代雄激素均显著升高。
- 血清11β-羟基雄烯二酮和11-酮雄烯二酮与胰岛素抵抗标志物显著相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the exact origin of hyperandrogenemia remains a matter of debate. Recent studies have highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen metabolism in humans. In this study, we analyzed the contribution of 11-oxygenated androgens to androgen excess in women with PCOS. METHODS: One hundred fourteen women with PCOS and 49 healthy control subjects underwent measurement of serum androgens by liquid chromatography-tandem mass spectrometry. Twenty-four-hour urinary androgen excretion was analyzed by gas chromatography-mass spectrometry. Fasting plasma insulin and glucose were measured for homeostatic model assessment of insulin resistance. Baseline demographic data, including body mass index, were recorded. RESULTS: As expected, serum concentrations of the classic androgens testosterone (P < 0.001), androstenedione (P < 0.001), and dehydroepiandrosterone (P < 0.01) were significantly increased in PCOS. Mirroring this, serum 11-oxygenated androgens 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, and 11-ketotestosterone were significantly higher in PCOS than in control subjects, as was the urinary 11-oxygenated androgen metabolite 11β-hydroxyandrosterone. The proportionate contribution of 11-oxygenated to total serum androgens was significantly higher in patients with PCOS compared with control subjects [53.0% (interquartile range, 48.7 to 60.3) vs 44.0% (interquartile range, 32.9 to 54.9); P < 0.0001]. Obese (n = 51) and nonobese (n = 63) patients with PCOS had significantly increased 11-oxygenated androgens. Serum 11β-hydroxyandrostenedione and 11-ketoandrostenedione correlated significantly with markers of insulin resistance. CONCLUSIONS: We show that 11-oxygenated androgens represent the majority of circulating androgens in women with PCOS, with close correlation to markers of metabolic risk.
引用
- O'Reilly MW, Kempegowda P, Jenkinson C, et al. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017. PMID: 27901631. doi:10.1210/jc.2016-3285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。